Mission statement · Company scope
“Our mission is to be the foremost biopharma company interrogating ecDNA biology to deliver transformative therapies that improve and extend the lives of patients with previously intractable oncogene amplified cancers.”
In use2026 – now1 sighting
First seenMar 2026Added
Last seenMar 2026Latest observation
Date created—Not published by the organization
Record
- Kind
- Mission
- Scope
- Company
- Style
- Market leadership (primary) · Impact · Innovation
- Leads with
- Rank
- Best for
- Climate & health
- Formula
- The [rank] [category] for [who]
- Tone
- Plain
- Length
- 30 words · reading grade 21.3
- Review status
- auto accepted · classifier rules-v0
- Quality score
- 0.76
- Record
- st_86531e5d5ec2588a
- Classification confidence
- 0.87
Sources1 sighting
SEC
SEC EDGAR filingsObserved 2026-03-09 · sec_sentence · 10-K · accession 0001193125-26-097543
View filing ↗0 to compareCompare